| 1 | 2379-03-5 | Benzeneacetic acid, 4-[4-(benzoyloxy)phenoxy]-3,5-dinitro-, ethyl ester | C23H18N2O9 | 466.4 | | |
| 2 | 2379-05-7 | Alanine, N-acetyl-3-[4-(p-hydroxyphenoxy)-3,5-dinitrophenyl]-, ethyl ester, benzoate (ester), L- (8CI) | C26H23N3O10 | 537.47 | | |
| 3 | 2379-09-1 | Benzoic acid, 4-[4-(benzoyloxy)phenoxy]-3,5-diiodo-, ethyl ester | C22H16I2O5 | 614.17 | | |
| 4 | 2379-10-4 | Benzeneacetic acid, 4-[4-(benzoyloxy)phenoxy]-3,5-diiodo-, ethyl ester | C23H18I2O5 | 628.2 | | |
| 5 | 2379-17-1 | 2-(3,4-DIMETHYLPHENYL)HEXAFLUOROISOPROPANOL | C11H10F6O | 272.19 | | |
| 6 | 2379-18-2 | Diazene, 1,2-bis(2,3,5,6-tetrafluorophenyl)-, 1-oxide | C12H2F8N2O | 342.14 | | |
| 7 | 2379-20-6 | Diazene, 1,2-bis(2,3,5,6-tetrafluorophenyl)- | C12H2F8N2 | 326.14 | | |
| 8 | 2379-55-7 | 2,3-Dimethylquinoxaline | C10H10N2 | 158.2 | 104-108°C(lit.) | |
| 9 | 2379-56-8 | 6-Nitroquinoxaline-2,3-dione | C8H5N3O4 | 207.14 | 345-347 °C (lit.) | |
| 10 | 2379-57-9 | Dnqx | C8H4N4O6 | 252.14 | >300°C | |
| 11 | 2379-59-1 | 2,3-Diethyl 2,3-quinoxalinedicarboxylate | C14H14N2O4 | 274.27 | | |
| 12 | 2379-60-4 | 2,3-Dichloro-6-Nitroquinoxaline | C8H3Cl2N3O2 | 244.03 | 151-155°C(lit.) | |
| 13 | 2379-61-5 | 2,3-DICHLORO-6,7-DINITROQUINOXALINE | C8H2Cl2N4O4 | 289.03 | 218-220°C | |
| 14 | 2379-74-0 | ORALITH BRILLIANT PINK R | C18H10Cl2O2S2 | 393.307 | | |
| 15 | 2379-75-1 | C.I. Vat Violet 3 | C20H14Cl2O2S2 | 421.35996 | | |
| 16 | 2379-76-2 | Vat Yellow 10 | C68H42N6O8 | 1071.1 | | |
| 17 | 2379-77-3 | Vat Red 32 | C36H16Cl2N2O4 | 611.43 | | 31.68ng/L at 20℃ |
| 18 | 2379-78-4 | C.I. Vat Orange 15 | C42H23N3O6 | 665.65 | | |
| 19 | 2379-79-5 | Vat Red 10 | C29H14N2O5 | 470.43186 | | 312.7ng/L at 20℃ |
| 20 | 2379-81-9 | Vat Black 27 | C42H23N3O6 | 665.648 | | |
| 21 | 2379-90-0 | Disperse Red 4 | C15H11NO4 | 269.25 | 224-226 °C | |
| 22 | 2379-92-2 | disodium 1,1'-methylenedi(naphthalene-2-sulphonate) | C21H14Na2O6S2 | 472.4418 | | |
| 23 | 2379-94-4 | 6-Hydroxyoctadecanoic acid methyl ester | C19H38O3 | 314.5 | | |
| 24 | 2379-96-6 | 7-Hydroxyoctadecanoic acid methyl ester | C19H38O3 | 314.5 | | |
| 25 | 2379-98-8 | 8-Hydroxyoctadecanoic acid methyl ester | C19H38O3 | 314.5 | | |
| 26 | 23790-08-1 | Moxipraquine | C24H38N4O2 | 414.58 | | |
| 27 | 23790-39-8 | 2,6-Di-tert-butyl-4-methylcyclohexanone (mixture of isomers) | C15H28O | 224.382 | | |
| 28 | 23790-48-9 | Antimony, tributyldihydroxy- (8CI,9CI) | C12H29O2Sb | 327.12 | | |
| 29 | 23790-49-0 | 2,2,3,3,4,4,5,5,6,6,6-Undecafluorohexanenitrile | C6F11N | 295.05 | | |
| 30 | 23790-50-3 | 2,4,6-Tris(perfluoropentyl)-s-triazine | C18F33N3 | 885.16 | | |
| 31 | 23790-75-2 | 5-bromotetracene | C18H11Br | 307.18 | | |
| 32 | 23790-80-9 | Retinal, (9-cis,13-cis)- | C20H28O | 284.44 | | |
| 33 | 23790-83-2 | 2-Butenoic acid, 2-methyl-, (4S,4aR,5S)-4,4a,5,6,7,9-hexahydro-3,4a,5-trimethyl-9-oxonaphtho[2,3-b]furan-4-yl ester, (2Z)- | C20H24O4 | 328.4 | | |
| 34 | 23790-99-0 | (+)-5-[(E)-1-Hydroxy-2-butenyl]tetrahydrofuran-2-one | C8H12O3 | 156.18 | | |
| 35 | 23791-00-6 | (+)-5-[(E)-1-Acetoxy-2-butenyl]tetrahydrofuran-2-one | C10H14O4 | 198.22 | | |
| 36 | 23791-20-0 | (5S,6S)-5-Acetoxy-5,6-dihydro-6-[(E)-1-propenyl]-2H-pyran-2-one | C10H12O4 | 196.2 | | |
| 37 | 23791-89-1 | 5α-Ethyl-2α-isopropyl-1,3-dioxane | C9H18O2 | 158.24 | | |
| 38 | 23791-92-6 | GLYCINE, SULFATE (2:1) | 2C2H5NO2.H2O4S | 248.211 | | |
| 39 | 23792-11-2 | Benzoic acid,4-[[(1,2,3,4-tetrahydro-2-quinoxalinyl)methyl]amino]-, ethyl ester | C18H21N3O2 | 311.37824 | | |
| 40 | 23792-56-5 | 1-Naphthalenesulfonic acid, 4-hydroxy-3-(2-phenyldiazenyl)- | C16H12N2O4S | 328.34 | | |
| 41 | 23792-61-2 | Benzenesulfonic acid, 4-[2-(4-nitrophenyl)diazenyl]- | C12H9N3O5S | 307.28 | | |
| 42 | 23792-68-9 | Pigment Yellow 188 | C34H30Cl2N6O4 | 657.55 | | |
| 43 | 2379231-16-8 | 1,4,7-Tris(1,1-dimethylethyl) 10-[2-oxo-2-(pentylamino)ethyl]-1,4,7,10-tetraazac… | | | | |
| 44 | 2379235-87-5 | 9H-Carbazole, 1,8-dibromo-3,6-bis(1,1-dimethylethyl)-9-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]- | C41H36Br2N4 | 744.56 | | |
| 45 | 2379241-70-8 | 1H-Indazol-3-amine, 6-methyl-N-(3,4,5-trimethoxyphenyl)- | C17H19N3O3 | 313.35 | | |
| 46 | 2379241-96-8 | 3-fluoro-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine | C6H7FN2O | 142.13 | | |
| 47 | 2379242-00-7 | (7R)-3-bromo-7-methyl-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine | C7H9BrN2O | 217.07 | | |
| 48 | 2379242-01-8 | 4-allyl-3-bromo-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine | C9H11BrN2O | 243.1 | | |
| 49 | 2379242-02-9 | 3-bromo-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine-4-carbonitrile | C7H6BrN3O | 228.05 | | |
| 50 | 2379242-05-2 | 3-bromo-6,7-dihydropyrazolo[5,1-c][1,4]oxazin-4-one | C6H5BrN2O2 | 217.02 | | |
| 51 | 2379248-09-4 | Aripiprazole Impurity 34 | | | | |
| 52 | 2379249-82-6 | TPA023B phosphoric acid salt | C21H18F2N5O5P | 489.38 | | |
| 53 | 2379271-71-1 | 6-[1-({[1,1'-biphenyl]-4-yl}methyl)-1H-indazole-7-amido]spiro[3.3]heptane-2-carboxylic acid | C29H27N3O3 | 465.54 | | |
| 54 | 2379272-01-0 | tert-butyl N-[6-(cyanomethyl)spiro[3.3]heptan-2-yl]carbamate | | | | |
| 55 | 2379272-80-5 | 1-((1,1’-biphenyl)-4-ylmethyl)-4-bromo-1H-indazole-7-carboxylicacidmethylester | | | | |
| 56 | 2379277-60-6 | Stephalonine L | C30H35NO10 | 569.61 | | |
| 57 | 2379279-96-4 | Boronic acid, B-[2-methoxy-3-(3,8,9,10-tetrahydrocyclopenta[c]pyrazolo[4,3-f]quinolin-7-yl)phenyl]- | C20H18BN3O3 | 359.19 | | |
| 58 | 2379284-04-3 | Q901 | C33H36FN9O2 | 609.7 | | |
| 59 | 2379284-84-9 | Pyrazolo[1,5-a]-1,3,5-triazin-4-amine, 8-(1-methylethyl)-2-(methylthio)-N-[[2-(6-nitro-1-isoquinolinyl)phenyl]methyl]- | C25H23N7O2S | 485.56 | | |
| 60 | 2379290-24-9 | 1.3.6.8-tetrabromopyrene-4,5,9,10-tetraketone | C16H2Br4O4 | 577.8 | | |
| 61 | 2379290-25-0 | 1,3,12,14-tetrabromobenzo[i]benzo[6',7']quinoxalino[2',3':9,10]phenanthro[4,5-abc]phenazine | C36H14Br4N4 | | | |
| 62 | 2379292-41-6 | Benzeneacetic acid, 4-(methoxycarbonyl)-α-methyl-, ethyl ester | C13H16O4 | 236.27 | | |
| 63 | 2379295-70-0 | 2-Pyrrolidinemethanol, α-[(phenylsulfonyl)methyl]-, (αS,2S)- | C12H17NO3S | | | |
| 64 | 2379295-73-3 | 2-Pyrrolidinemethanol, α-[(phenylsulfonyl)methyl]-, (αR,2R)- | C12H17NO3S | 255.33 | | |
| 65 | 2379296-13-4 | (L)-PSM-fG-Sp | C47H50FN6O10PS | 940.97 | | |
| 66 | 2379296-14-5 | Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-3′-O-[(1S,3S,3aS)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 831.84 | | |
| 67 | 2379296-15-6 | Cytidine, N-acetyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-3′-O-[(1S,3S,3aS)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 872.9 | | |
| 68 | 2379296-16-7 | Adenosine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-3′-O-[(1S,3S,3aS)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 958.99 | | |
| 69 | 2379296-17-8 | (L)-PSM-mA-Sp | C51H51N6O10PS | 971.03 | | |
| 70 | 2379296-18-9 | Adenosine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-3′-O-[(1S,3S,3aS)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 1015.08 | | |
| 71 | 2379296-19-0 | (L)-PSM-moeG-Sp | C50H57N6O12PS | 997.06 | | |
| 72 | 2379296-20-3 | Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-5-methyl-3′-O-[(1S,3S,3aS)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 901.96 | | |
| 73 | 2379296-21-4 | (L)-PSM-moe5C-Sp | C53H57N4O12PS | 1005.08 | | |
| 74 | 2379296-23-6 | Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-N-(2-methyl-1-oxopropyl)-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 940.97 | | |
| 75 | 2379296-24-7 | Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 831.84 | | |
| 76 | 2379296-25-8 | Cytidine, N-acetyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 872.9 | | |
| 77 | 2379296-26-9 | Adenosine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 958.99 | | |
| 78 | 2379296-27-0 | (D)-PSM-mA-Rp | C51H51N6O10PS | 971.03 | | |
| 79 | 2379296-28-1 | Adenosine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 1015.08 | | |
| 80 | 2379296-29-2 | Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | C50H57N6O12PS | 997.06 | | |
| 81 | 2379296-30-5 | Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-5-methyl-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 901.96 | | |
| 82 | 2379296-31-6 | Cytidine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-5-methyl-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | | 1005.08 | | |
| 83 | 2379296-32-7 | Cytidine, N-acetyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-3′-O-[(1R,3R,3aR)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]- | C44H47N4O10PS | 854.91 | | |
| 84 | 2379299-18-8 | 4-Bromo-4′-chloro-spiro[9H-fluorene-9,9′-[9H]xanthene] | | | | |
| 85 | 2379299-19-9 | 2-Bromo-2′-chloro-spiro[9H-fluorene-9,9′-[9H]xanthene] | C25H14BrClO | 445.74 | | |
| 86 | 2379299-22-4 | 2-Bromo-2′-chlorospiro[9H-fluorene-9,9′-[9H]thioxanthene] | C25H14BrClS | 461.8 | | |
| 87 | 23793-23-9 | 4-Pyridinemethanol, 3-hydroxy-2-methyl-5-[(methylthio)methyl]-, hydrochloride (1:1) | C9H14ClNO2S | 235.73 | | |
| 88 | 23793-35-3 | 4-Pyridinemethanol,3-hydroxy-2-methyl-5-[(methylsulfinyl)methyl]-, hydrochloride (1:1) | C9H14ClNO3S | 251.73036 | | |
| 89 | 23793-55-7 | 1-(2-phenylethyl)piperidine-4-carboxamide | C14H20N2O | 232.32 | | |
| 90 | 23793-63-7 | 1-Piperidineethanol, 2,2,6,6-tetramethyl-α-[(2-methylphenoxy)methyl]-, hydrochloride (1:1) | C19H32ClNO2 | 341.92 | | |
| 91 | 23793-77-3 | 1(2H)-Pyridineethanol, 3,6-dihydro-2,2,6,6-tetramethyl-α-(phenoxymethyl)-, hydrochloride (1:1) | C18H28ClNO2 | 325.88 | | |
| 92 | 23793-79-5 | 1-Piperidineethanol, 2,2,6,6-tetramethyl-α-[(3-methylphenoxy)methyl]-, hydrochloride (1:1) | C19H32ClNO2 | 341.92 | | |
| 93 | 23793-80-8 | 1-Piperidineethanol, α-[(2,6-dimethylphenoxy)methyl]-2,2,6,6-tetramethyl-, hydrochloride (1:1) | C20H34ClNO2 | 355.95 | | |
| 94 | 2379310-39-9 | 2-Penten-1-one, 5-[(1R,4aS,6R,8aS)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]-1-[4-(dimethylamino)-1-piperidinyl]-3-methyl-, (2E)- | C27H46N2O2 | 430.67 | | |
| 95 | 2379311-49-4 | Benzoic acid, 4-fluoro-2-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester | C14H18BFO5 | 296.1 | | |
| 96 | 2379311-62-1 | (S)-2-(1-Aminoethyl)-4-fluorophenol hydrochloride | C8H11ClFNO | 191.63 | | |
| 97 | 2379312-74-8 | Zurletrectinib Impurity 33 | | | | |
| 98 | 2379312-75-9 | Zurletrectinib Impurity 32 | | | | |
| 99 | 2379320-84-8 | Carbamic acid,N-(7-iodopyrrolo[2,1-f][1,2,4]triazin-4-yl)-, 1,1-dimethylethyl este | C11H13IN4O2 | 360.15 | | |
| 100 | 2379321-06-7 | Carbamic acid, N-[7-[2,3,5-tris-O-(phenylmethyl)-D-ribofuranosyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-, 1,1-dimethylethyl ester | C37H40N4O7 | 652.74 | | |
| 101 | 2379321-22-7 | 1-(4-Chloro-2-fluorophenyl)-3,5-dimethyl-1H-pyrazole-4-carbaldehyde | C12H10ClFN2O | 252.67 | | |
| 102 | 2379321-41-0 | 2-Bromo-4-fluoro-3-(methoxymethyl)-1-methylbenzene | C9H10BrFO | 233.08 | | |
| 103 | 2379321-65-8 | 1-(4-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbaldehyde | C10H6ClFN2O | 224.6188432 | | |
| 104 | 2379321-70-5 | 3-Bromo-2-chloro-5-isopropylbenzoic acid | C10H10BrClO2 | 277.54 | | |
| 105 | 2379322-81-1 | 3-Fluoro-2-(methoxymethyl)-6-methylbenzaldehyde | C10H11FO2 | 182.19 | | |
| 106 | 2379322-82-2 | 2-Ethoxy-1,4-difluoro-3-methoxybenzene | C9H10F2O2 | 188.17 | | |
| 107 | 2379322-83-3 | (5-Bromo-2-fluoro-4-methylphenyl)(methyl)sulfane | C8H8BrFS | 235.12 | | |
| 108 | 2379325-11-6 | Methanone, [4-fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]phenyl]-4-piperidinyl- | C24H25F2N3O2 | 425.47 | | |
| 109 | 2379325-42-3 | Duloxetine EP Impurity F (oxalate)Q: What is Duloxetine EP Impurity F (oxalate) Q: What is the CAS Number of Duloxetine EP Impurity F (oxalate) | C20H21NO5S | 387.45 | | |
| 110 | 2379335-06-3 | Benzenesulfonamide, N-[[[4-(4-bromophenyl)-2-thiazolyl]amino]carbonyl]-4-methyl- | C17H14BrN3O3S2 | 452.35 | | |
| 111 | 2379336-76-0 | L-Tryptophanamide, N2-[(2-mercapto-3-pyridinyl)methyl]-L-ornithyl-L-lysyl-N-[(4'-carboxy-3-mercapto[1,1'-biphenyl]-2-yl)methyl]-N2-methyl-, cyclic (1→3)-thioether | C43H50N8O5S | 790.98 | | |
| 112 | 2379344-48-4 | 6-Methoxy-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one | | | | |
| 113 | 2379346-41-3 | Benzamide, 5-[(cyclopropylcarbonyl)amino]-2-fluoro-4-methyl-N-[6-[4-[(1R)-2,2,2-trifluoro-1-methylethyl]-4H-1,2,4-triazol-3-yl]-2-pyridinyl]- | C22H20F4N6O2 | 476.43 | | |
| 114 | 2379387-10-5 | 2-Propenamide, N-[4-(1,2,2-triphenylethenyl)phenyl]- | C29H23NO | 401.5 | | |
| 115 | 2379390-63-1 | 3(2H)-Pyridazinone, 4-bromo-5-chloro-2-[[2-(trimethylsilyl)ethoxy]methyl]- | C10H16BrClN2O2Si | 339.69 | | |
| 116 | 2379390-64-2 | 3(2H)-Pyridazinone, 5-chloro-4-(trifluoromethyl)-2-[[2-(trimethylsilyl)ethoxy]methyl]- | C11H16ClF3N2O2Si | 328.79 | | |
| 117 | 2379390-73-3 | NCT-TFP | C41H34F4N2O5 | 710.71 | | |
| 118 | 2379390-76-6 | Probe 388-9 | C36H49F3N8O5S | 762.89 | | |
| 119 | 2379390-80-2 | 3(2H)-Pyridazinone, 5-[1,3-dihydro-5-(4-piperidinyloxy)-2H-isoindol-2-yl]-4-(trifluoromethyl)- | C18H19F3N4O2 | 380.36 | | |
| 120 | 2379392-61-5 | IDTTB6-Br-CHO | C69H73BrOS4 | | | |
| 121 | 2379394-94-0 | Cyclobutanol, 3-(aminomethyl)-1-methyl-, hydrochloride (1:1), cis- | C6H14ClNO | 151.63 | | |
| 122 | 23794-13-0 | 2-Bromo-1-(6-chloropyridin-3-yl)-ethanone | C7H5BrClNO | 234.48 | 79-80℃ | |
| 123 | 23794-15-2 | 1-(2-chloropyridin-4-yl)ethanone | C7H6ClNO | 155.58 | 36.5 °C | |
| 124 | 23794-16-3 | 2-bromo-1-(2-chloropyridin-4-yl)ethanone | C7H5BrClNO | 234.48 | 55 °C | |
| 125 | 23794-67-4 | Carbamic acid, N-[4-(trifluoromethyl)phenyl]-, 4-nitrophenyl ester | C14H9F3N2O4 | 326.23 | | |
| 126 | 23794-73-2 | Carbamic acid, N-[4-(trifluoromethyl)phenyl]-, ethyl ester | C10H10F3NO2 | 233.19 | | |
| 127 | 23794-77-6 | Carbamic acid, N-[4-(trifluoromethyl)phenyl]-, methyl ester | C9H8F3NO2 | 219.16 | | |
| 128 | 2379402-85-2 | 2-Pyrazinecarboxamide, N-[(1S)-2-[(3-hydroxy-3-methyl-1-oxobutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]- | C19H22N4O4 | 370.4 | | |
| 129 | 2379402-86-3 | methyl 3-((tert-butyldimethylsilyl)oxy)-3-methylbutanoate | | | | |
| 130 | 2379404-33-6 | (S,R,S)-AHPC-C1-Br | C24H31BrN4O4S | 551.5 | | |
| 131 | 2379405-61-3 | 2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N-(4-phenyl-2-thiazolyl)-, (2E)- | C19H13N3O3S | 363.39 | | |
| 132 | 2379409-91-1 | Urea, N-[(1R)-2,3-dihydro-2',4'-dioxo-3'-[2-oxo-2-[(3R)-1,3,4,5-tetrahydro-3-methyl-2H-2-benzazepin-2-yl]ethyl]spiro[1H-indene-1,5'-oxazolidin]-5-yl]-N'-methyl- | C26H28N4O5 | 476.52 | | |
| 133 | 2379416-47-2 | Spiro[imidazolidine-4,1'-[1H]indene]-2,5-dione, 1-[2-[(3S)-7-fluoro-2,3-dihydro-3-(trifluoromethyl)-1,4-benzoxazepin-4(5H)-yl]-2-oxoethyl]-2',3'-dihydro-5'-(1-methyl-1H-pyrazol-4-yl)-, (1'R)- | C27H23F4N5O4 | 557.5 | | |
| 134 | 2379416-48-3 | Spiro[imidazolidine-4,1'-[1H]indene]-2,5-dione, 1-[2-[(3S)-7-fluoro-2,3-dihydro-3-(trifluoromethyl)-1,4-benzoxazepin-4(5H)-yl]-2-oxoethyl]-2',3'-dihydro-5'-(1-methyl-1H-pyrazol-4-yl)-, (1'S)- | C27H23F4N5O4 | 557.5 | | |
| 135 | 2379422-72-5 | LY3154885 | C23H23Cl2N3O2 | 444.35 | | |
| 136 | 2379428-43-8 | 1,1-Dioxo-1l6-thiochroman-3-ylamine | C9H11NO2S | 197.25 | | |
| 137 | 2379437-10-0 | 5,10,15,20-Tetrakis(pentafluorophenyl)-21h,23h-porphine-Magnesium chloride oxide | | | | |
| 138 | 2379438-80-7 | Benzoic acid, 3,5-dihydroxy-, (2E)-2-[(4-hydroxy-3-nitrophenyl)methylene]hydrazide | C14H11N3O6 | 317.25 | | |
| 139 | 2379454-98-3 | 2379454-98-3 | C22H12N2O4S | 400.41 | | |
| 140 | 2379460-04-3 | 9-chloronaphtho[2,1-b]benzofuran | C16H9ClO | 252.7 | | |
| 141 | 2379460-31-6 | 2-[3,5-Difluoro-4-(trifluoromethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxabo... | C13H14BF5O3 | 324.05 | | |
| 142 | 23795-02-0 | Ethyl P-Hydroxyhydrocinnamate | C11H14O3 | 194.23 | 40 °C | |
| 143 | 23795-03-1 | 4-[(Dipropylamino)sulfonyl]benzoic acid sodium salt | C13H18NNaO4S | 307.341 | | |
| 144 | 23795-19-9 | Piperidinium, 1-ethyl-1-[2-[(2-hydroxy-2,2-diphenylacetyl)oxy]ethyl]- | C23H30NO3+ | 368.5 | | |
| 145 | 23795-34-8 | 2-Propenamide, N,N-bis(1-methylethyl)-3-phenyl- | C15H21NO | 231.33 | | |
| 146 | 23795-68-8 | (2E)-2-cyano-N,N-diethyl-3-(4-methoxyphenyl)prop-2-enamide | C15H18N2O2 | 258.32 | | |
| 147 | 2379518-92-8 | Benzoic acid, 3-(3-methyl-1H-indazol-5-yl)-, ethyl ester | C17H16N2O2 | 280.32 | | |
| 148 | 2379518-93-9 | Benzoic acid, 3-(3-methyl-1H-indazol-5-yl)- | C15H12N2O2 | 252.27 | | |
| 149 | 2379519-74-9 | Benzoic acid, 3-(1H-indazol-5-yl)-, ethyl ester | C16H14N2O2 | 266.3 | | |
| 150 | 2379527-49-6 | EP300/CBP-IN-2 | C30H29D3F2N4O3 | 537.62 | | |
| 151 | 2379527-72-5 | Phenanthro[1,2-b]furan-7,10,11(6H)-trione, 1-[(acetyloxy)methyl]-6,6-dimethyl- | C21H16O6 | 364.35 | | |
| 152 | 2379530-86-4 | 1,2-Propanediol, 3-[(3-methyl-2-buten-1-yl)oxy]- | C8H16O3 | 160.21 | | |
| 153 | 2379538-57-3 | (3-Bromo-2-chloro-5-fluorophenyl)boronic acid | C6H4BBrClFO2 | 253.26 | | |
| 154 | 2379550-55-5 | 2-Methyl-1,2,3,4-tetrahydro-isoquinoline-6-boronic acid picol ester hydrochloride | C16H25BClNO2 | 309.64 | | |
| 155 | 2379550-82-8 | SHS4121705 | C11H6F3N5O3 | 313.19 | | |
| 156 | 2379556-15-5 | Glycine, N-[[5-[[[(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)amino]carbonyl]amino]-2-pyridinyl]carbonyl]-2-[2-(2H-tetrazol-5-yl)ethyl]-, (2S)- | C16H18N12O5 | 458.39 | | |
| 157 | 2379556-22-4 | L-Glutamic acid, N-[[5-[[2-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)acetyl]amino]-3-fluoro-2-pyridinyl]carbonyl]- | C17H18FN7O7 | 451.37 | | |
| 158 | 2379558-42-4 | 2-[5-Bromo-2-(trifluoromethyl)phenyl]-1,3-dioxolane | C10H8BrF3O2 | 297.07 | | |
| 159 | 2379560-55-9 | 3-(1,2,2-triphenylvinyl)thiophene | C24H18S | 338.47 | | |
| 160 | 2379560-80-0 | 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZO[D]ISOXAZOLE | C13H16BNO3 | 245.08 | | |
| 161 | 2379560-81-1 | 3-methyl-benzodisoxazole-4-boroniic acid picol ester | C14H18BNO3 | 259.11 | | |
| 162 | 2379560-85-5 | Pyrazolo1,5-apyridine-5-boronic acid picol ester | C13H17BN2O2 | 244.1 | | |
| 163 | 2379560-87-7 | 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indazole-3-carboxylic acid methyl ester | C15H19BN2O4 | 302.13 | | |
| 164 | 2379560-89-9 | 2-hydroxy-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | C13H17BO4 | 248.08 | | |
| 165 | 2379560-94-6 | 2-Boc-5-Fluoro-1,2,3,4-tetrahydro-isoquinoline-7-boronic acid picol ester | C20H29BFNO4 | 377.26 | | |
| 166 | 2379560-96-8 | 1-Methyl-piperidine-4-boronic acid picol ester hydrochloride | C12H25BClNO2 | 261.6 | | |
| 167 | 2379561-01-8 | 2-Boc-5-Fluoro-1,2,3,4-tetrahydro-isoquinoline-6-boronic acid picol ester | C20H29BFNO4 | 377.26 | | |
| 168 | 2379569-17-0 | PAR2 (1-6) amide (human) (trifluoroacetate salt) | C30H55F3N8O9 | 728.81 | | |
| 169 | 2379569-54-5 | 2-(3-((tert-Butoxycarbonyl)amino)bicyclo[1.1.1]pentan-1-yl)propanoic acid | C13H21NO4 | 255.31 | | |
| 170 | 2379570-48-4 | IDO1-IN-12 | C21H19F3N2O2 | 388.39 | | |
| 171 | 2379572-21-9 | 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[[2-fluoro-4-[[3-(4-morpholinyl)-1-azetidinyl]methyl]phenyl]methyl]amino]- | C28H30FN5O5 | 535.57 | | |
| 172 | 2379572-33-3 | Mezigdomide Impurity 273 | | | | |
| 173 | 2379572-34-4 | CC-99282 | C28H30FN5O5 | 535.58 | | |
| 174 | 2379572-38-8 | Mezigdomide Impurity 278 | | | | |
| 175 | 2379572-39-9 | Mezigdomide Impurity 176 | | | | |
| 176 | 2379572-45-7 | Mezigdomide Impurity 196 | | | | |
| 177 | 2379572-47-9 | Mezigdomide Impurity 164 | | | | |
| 178 | 2379572-60-6 | Mezigdomide Impurity 110 | | | | |
| 179 | 2379572-61-7 | Mezigdomide Impurity 95 | | | | |
| 180 | 2379577-82-7 | 6(5H)-Pteridinone, 7,8-dihydro-4,7,8-trimethyl-2-[[[1-[[6-(trifluoromethyl)-3-pyridinyl]methyl]-1H-pyrazol-4-yl]methyl]amino]-, (7S)- | C20 H21 F3 N8 O | 446.43 | | |
| 181 | 2379583-81-8 | 6(5H)-Pteridinone, 2-chloro-7,8-dihydro-4,7,8-trimethyl-, (7S)- | C9H11ClN4O | 226.66 | | |
| 182 | 2379584-01-5 | (S)-2-Chloro-7-methyl-7,8-dihydropteridin-6(5H)-one | C7H7ClN4O | 198.61 | | |
| 183 | 2379585-93-8 | 1H-Pyrazole-4-methanamine, 1-[[6-(trifluoromethyl)-3-pyridinyl]methyl]- | C11H11F3N4 | 256.23 | | |
| 184 | 23796-66-9 | 1,4-Dioxino[2,3-g]quinoline-8-carboxylic acid, 6-ethyl-2,3,6,9-tetrahydro-9-oxo- | C14H13NO5 | 275.26 | | |
| 185 | 23796-81-8 | 2-[(3,4-Dihydronaphthalen-2-yl)methyl]hydrocinnamic acid methyl ester | C21H22O2 | 306.4 | | |
| 186 | 2379621-81-3 | Benzenebutanoic acid, β-[[(3R)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]amino]-2,4,5-trifluoro-, (βR)- | C25H26F6N2O5 | 548.48 | | |
| 187 | 2379626-93-2 | 2-Azaspiro[3.3]heptane-2-carboxylic acid, 6-methoxy-, 1,1-dimethylethyl ester | C12H21NO3 | 227.3 | | |
| 188 | 2379639-01-5 | BODIPY-604/645 | C34H26BF2N3O2 | 557.41 | | |
| 189 | 2379639-08-2 | BODIPY-606/636 | C28H18BF2N3S2 | 509.4 | | |
| 190 | 2379639-40-2 | 2-(5-(4-methoxyphenyl)-1H-pyrrol-3-yl)pyridine | C16H14N2O | 250.3 | | |
| 191 | 2379639-42-4 | 3-(5-(4-methoxyphenyl)-1H-pyrrol-3-yl)pyridine | C16H14N2O | 250.3 | | |
| 192 | 2379639-44-6 | 2-(4-methoxyphenyl)-4-(thiophen-2-yl)-1H-pyrrole | C15H13NOS | 255.34 | | |
| 193 | 2379639-46-8 | 8-methoxy-3-(pyridin-3-yl)-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole | C18H16N2O | 276.34 | | |
| 194 | 2379639-48-0 | 4-(5-phenyl-1H-pyrrol-3-yl)pyridine | C15H12N2 | 220.28 | | |
| 195 | 2379639-51-5 | 3-(4-phenyl-1H-pyrrol-2-yl)pyridine | C15H12N2 | 220.28 | | |
| 196 | 2379639-53-7 | 4-(4-phenyl-1H-pyrrol-2-yl)pyridine | C15H12N2 | 220.28 | | |
| 197 | 2379651-37-1 | 5-Benzyl-2-oxa-5-aza-bicyclo2.2.2octane-4-carboxylic acid | C14H17NO3 | 247.29 | | |
| 198 | 2379651-39-3 | 5-Trifluoromethyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester | C13H20F3NO4 | 311.3 | | |
| 199 | 2379651-41-7 | 5-Benzyl-2-oxa-5-aza-bicyclo2.2.2octane-4-carbonitrile | C14H16N2O | 228.28964 | | |
| 200 | 2379651-42-8 | 2-(1-Amino-2-methyl-propyl)-pyridin-4-ylamine dihydrochloride | C9H17Cl2N3 | 238.15738 | | |
| 201 | 2379651-46-2 | rel-(1R,2S,5R)-6-Aza-bicyclo3.1.1heptane-2-carboxylic acid | C7H11NO2 | 141.17 | | |
| 202 | 2379651-47-3 | Pyrrolo1,2-apyrimidin-3-ylamine dihydrochloride | C7H8ClN3 | 169.61 | | |
| 203 | 2379671-78-8 | 2-Propenamide, 3-(3-bromo-4,5-dihydroxyphenyl)-2-cyano-N-[4-(phenylmethyl)-2-thiazolyl]-, (2E)- | | | | |
| 204 | 2379679-90-8 | Fmoc-L-Asp(CSY)-OH | C23H22N2O5S | 438.5 | | |
| 205 | 2379694-79-6 | [1,10]Phenanthroline-3,8-dicarboxylic acid | C14H8N2O4 | 268.22 | | |
| 206 | 2379695-44-8 | (S)-2-(1-(imidazo[1,2-a]pyridin-6-yl)ethyl)isoindoline-1,3-dione | C17H13N3O2 | 291.3 | | |
| 207 | 2379701-99-0 | 2-fluoro-4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazol-3-yl)phenol | C14H20FN3O2Si | 309.41 | | |
| 208 | 2379702-01-7 | 5-aminoindoline-2,3-dione hydrochloride | C8H7ClN2O2 | 198.61 | | |
| 209 | 2379707-43-2 | 2-bromobenzyl methyl carbonate | | | | |
| 210 | 2379717-40-3 | 3-bromo-6-chlorodibenzofuran | C12H6BrClO | 281.53244 | | |
| 211 | 2379717-75-4 | 1-chloro-8-phenyl-Dibenzofuran | C18H11ClO | 278.73 | | |
| 212 | 2379717-76-5 | 4,4,5,5-tetramethyl-2-(8-phenyldibenzo[b,d]furan-1-yl)-1,3,2-dioxaborolane | C24H23BO3 | 370.25 | | |
| 213 | 2379717-87-8 | Dibenzofuran, 1-chloro-4-phenyl- | C18H11ClO | 278.73 | | |
| 214 | 2379717-89-0 | Dibenzofuran, 1-chloro-2-phenyl- | C18H11ClO | 278.73 | | |
| 215 | 2379727-88-3 | Urea, N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[2,3,4,9-tetrahydro-7-(1-methyl-1H-pyrazol-4-yl)-1H-carbazol-3-yl]- | C24H21ClF3N5O | 487.9 | | |
| 216 | 2379727-90-7 | Antitumor agent-19 | C24H21ClF3N5O | 487.9 | | |
| 217 | 2379735-04-1 | N-methacryloyl-2-p-ethylphenylbenzimidazole | | | | |
| 218 | 2379735-05-2 | 1-(2-(4-isopropylphenyl)-1H-benzo[d]imidazol-1-yl)-2-methylprop-2-en-1-one | | | | |
| 219 | 2379735-06-3 | 1-(2-(4-fluorophenyl)-1H-benzo[d]imidazol-1-yl)-2-methylprop-2-en-1-one | | | | |
| 220 | 2379735-08-5 | 1-(2-(2-chlorophenyl)-1H-benzo[d]imidazol-1-yl)-2-methylprop-2-en-1-one | | | | |
| 221 | 2379768-79-1 | 1,3,2-Dioxaborolane, 2-(2,2-difluoroethenyl)-4,4,5,5-tetramethyl- | C8H13BF2O2 | 190 | | |
| 222 | 2379769-98-7 | 2-(Difluoromethyl)-6-phenylpyridine | | | | |
| 223 | 2379770-11-1 | Cyclohexanecarboxylic acid, 4-(difluoromethyl)-, cis- | C8H12F2O2 | 178.18 | | |
| 224 | 2379770-87-1 | cis-4-Difluoromethyl-cyclohexylamine | C7H13F2N | 149.18 | | |
| 225 | 2379776-40-4 | Plozasiran | | | | |
| 226 | 2379776-41-5 | Plozasiran sodium | | | | |
| 227 | 2379777-37-2 | 2-Pentenoic acid, 3-methyl-5-[(1R,2R,4R,4aR,8aS)-1,2,3,4,4a,7,8,8a-octahydro-1,2,4a,5-tetramethyl-4-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-1-naphthalenyl]-, (2E)- | C25H38O4 | 402.57 | | |
| 228 | 2379783-61-4 | 4-[(3R)-3-[2-Chloro-4-(methylsulfonyl)phenyl]tetrahydro-1,4-oxazepin-4(5H)-yl]-6-methyl-2-pyrimidinamine | C17H21ClN4O3S | 396.89 | | |
| 229 | 2379783-62-5 | 4-[(3S)-3-[2-Chloro-4-(methylsulfonyl)phenyl]tetrahydro-1,4-oxazepin-4(5H)-yl]-6-methyl-2-pyrimidinamine | C17H21ClN4O3S | 396.89 | | |
| 230 | 2379792-68-2 | 1,3,2-Dioxaborolane, 2-(2-fluoro-5-iodophenyl)-4,4,5,5-tetramethyl- | C12H15BFIO2 | 347.96 | | |
| 231 | 2379795-13-6 | (R)-6-Bromo-3-methyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one | | | | |
| 232 | 23798-10-9 | m-Terphenyl, 4,4-bis(p-methoxystyryl)-5-p-(p-methoxystyryl)phenyl- | C51H42O3 | 702.88 | | |
| 233 | 2379805-59-9 | Unasnemab | | | | |
| 234 | 2379812-69-6 | ethynesulfonic acid;sodium hydride | | | | |
| 235 | 2379818-47-8 | 3TOO610-2Br | C46H70Br2O4S3 | | | |
| 236 | 2379819-70-0 | Abemaciclib Impurity 25 | C24H37N7 | 423.6 | | |
| 237 | 2379819-71-1 | 2-Pyridinamine, 5-[(4-ethyl-1-piperazinyl)methyl]-N,N-bis(trimethylsilyl)- | C18H36N4Si2 | 364.68 | | |
| 238 | 2379821-64-2 | 5-Bromo-6-chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine | C7H3BrClIN2 | 357.37 | | |
| 239 | 2379821-65-3 | 5-Bromo-6-chloro-3-iodo-1-methyl-1H-pyrrolo[2,3-b]pyridine | C8H5BrClIN2 | 371.4 | | |
| 240 | 2379824-03-8 | 2379824-03-8 | C22H34O4Si2 | 418.67 | | |
| 241 | 2379829-81-7 | (3-chloronaphthalen-1-yl)boronic acid | C10H8BClO2 | | | |
| 242 | 2379852-12-5 | [1,1'-Biphenyl]-2,2'-diol, 3,3'-diethenyl-5,5'-dimethoxy- | C18H18O4 | 298.33 | | |
| 243 | 2379870-45-6 | Thalidomide-4-O-C10-COOH | C24H30N2O7 | 458.50 | | |
| 244 | 2379870-47-8 | 5-Hexynoic acid, 6-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]- | C19H18N2O5 | 354.36 | | |
| 245 | 2379874-15-2 | Etidocaine Hydrochloride Impurity 14 | | | | |
| 246 | 2379874-17-4 | Etidocaine Hydrochloride Impurity 27 | | | | |
| 247 | 2379875-04-2 | Cyclohexanecarboxylic acid, 4-oxo-, triphenylmethyl ester | C26H24O3 | 384.47 | | |
| 248 | 2379877-88-8 | 2379877-88-8 | C69H107ClO46S7 | | | |
| 249 | 2379877-89-9 | Sugammadex Impurity 19 | | | | |
| 250 | 2379877-90-2 | Sugammadex sodium impurity | C69H108O46S8 | 1930.1 | | |
| 251 | 2379877-91-3 | Sugammadex Impurity 22 （Org197339-1） | C69H109NaO46S8 | 1954.05 | | |
| 252 | 2379877-99-1 | 2-Pyridinemethanol, α,α-bis(4-hydroxyphenyl)- | C18H15NO3 | 293.32 | | |
| 253 | 2379878-04-1 | 2-Pyridinemethanol, α,α-bis[4-(sulfooxy)phenyl]- | C18H15NO9S2 | 453.44 | | |
| 254 | 2379878-05-2 | 2-Pyridinemethanol, α,α-bis[4-(sulfooxy)phenyl]-, sodium salt (1:2) | C18H16NNaO9S2 | 477.43 | | |
| 255 | 2379884-33-8 | Phenol, 4-bromo-2-(1-methylethyl)-, compd. with 1,4-diazabicyclo[2.2.2]octane (2:1) | C15H23BrN2O | 327.27 | | |
| 256 | 2379889-71-9 | Lazuvapagon | C27H32N4O3 | 460.57 | | |
| 257 | 2379889-82-2 | Puromycin-bis(PEG2-amide)-Biotin | C46H71N13O13S | 1046.2 | | |
| 258 | 2379890-92-1 | Anti-MRSA agent 24 | | | | |
| 259 | 23799-25-9 | 1-Methyl-4-methylenecycloheptane | C9H16 | 124.22 | | |
| 260 | 23799-55-5 | 2-((5-Chlorobenzo[b]thiophen-3-yl)methyl)isoindoline-1,3-dione | C17H10ClNO2S | 327.7848 | | |
| 261 | 23799-59-9 | (5-METHYL-1-BENZOTHIEN-3-YL)ACETONITRILE | C11H9NS | 187.26 | | |
| 262 | 23799-60-2 | 5-CHLOROTHIANAPHTHENE-3-ACETONITRILE | C10H6ClNS | 207.68 | 133 °C | |
| 263 | 23799-61-3 | 5-BROMO-3-CYANOMETHYL-BENZO[B]THIOPHENE | C10H6BrNS | 252.13 | | |
| 264 | 23799-77-1 | 2-(5-chloro-1-benzothiophen-3-yl)ethan-1-amine hydrochloride | C10H11Cl2NS | 248.17 | | |
| 265 | 23799-80-6 | Benzo[b]thiophene-2-ethanamine,5-bromo-, hydrochloride (1:1) | C10H11BrClNS | 292.62304 | | |
| 266 | 23799-83-9 | Benzo[b]thiophene-3-ethanamine, 5-chloro-N-methyl-, hydrochloride (1:1) | C11H13Cl2NS | 262.19 | | |
| 267 | 23799-86-2 | Benzo[b]thiophene-3-ethanamine, N,N,5-trimethyl-, hydrochloride (1:1) | C13H18ClNS | 255.8 | | |
| 268 | 23799-90-8 | Urea, N-(benzo[b]thien-3-ylmethyl)- | C10H10N2OS | 206.26 | | |
| 269 | 23799-91-9 | Urea, N-[(5-chlorobenzo[b]thien-3-yl)methyl]- | C10H9ClN2OS | 240.71 | | |
| 270 | 23799-92-0 | Urea, N-(2-benzo[b]thien-3-ylethyl)- | C11H12N2OS | 220.29 | | |
| 271 | 23799-93-1 | Urea, N-[(5-chlorobenzo[b]thien-2-yl)methyl]- | C10H9ClN2OS | 240.71 | | |
| 272 | 23799-94-2 | Urea, N-[(5-bromobenzo[b]thien-2-yl)methyl]- | C10H9BrN2OS | 285.16 | | |
| 273 | 23799-95-3 | Urea, N-[2-(5-chlorobenzo[b]thien-2-yl)ethyl]- | C11H11ClN2OS | 254.74 | | |
| 274 | 23799-96-4 | Urea, N-[2-(5-bromobenzo[b]thien-2-yl)ethyl]- | C11H11BrN2OS | 299.19 | | |
| 275 | 2379905-31-2 | cis-2-Methyl-pyrrolidin-3-ol hydrochloride | C5H12ClNO | 137.61 | | |
| 276 | 2379912-85-1 | Chiglitazar Impurity 16 | | | | |
| 277 | 2379912-88-4 | Chiglitazar Impurity 20 | | | | |
| 278 | 2379914-59-5 | 2-Pyridinecarboxylic acid, 6-bromo-1,4-dihydro-3-methoxy-4-oxo-, methyl ester | C8H8BrNO4 | 262.06 | | |
| 279 | 2379914-69-7 | methyl 3-methoxy-6-(3-methylbut-3-en-1-yl)-4-oxo-1,4-dihydropyridine-2-carboxylate | | | | |
| 280 | 2379917-15-2 | 2-Chloro-N-((dimethylamino)methylene)-4-fluorobenzamide | C10H10ClFN2O | 228.65 | | |
| 281 | 2379917-16-3 | N-((Dimethylamino)methylene)-2,4-difluorobenzamide | C10H10F2N2O | 212.2 | | |
| 282 | 2379917-17-4 | 4-Chloro-N-((dimethylamino)methylene)-2-fluorobenzamide | C10H10ClFN2O | 228.65 | | |
| 283 | 2379918-31-5 | 2-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-5-methoxypyrimidin-4(3H)-one | C11H7ClF3N3O2 | 305.64 | | |
| 284 | 2379918-32-6 | Benzene, 1-bromo-2-ethynyl-4-(trifluoromethoxy)- | C9H4BrF3O | 265.03 | | |
| 285 | 2379918-33-7 | 8-Bromo-1-fluorophenazine | C12H6BrFN2 | 277.09 | | |
| 286 | 2379918-35-9 | 3-Chloro-5-(trifluoromethyl)picolinimidohydrazide | C7H6ClF3N4 | 238.6 | | |
| 287 | 2379918-37-1 | N-[1-(2-Fluorophenyl)ethyl]prop-2-yn-1-amine hydrochloride | | | | |
| 288 | 2379918-41-7 | Ethyl 8-fluoro-2-(trifluoromethyl)imidazo(1,2-a)pyridine-3-carboxylate | C11H8F4N2O2 | 276.19 | | |
| 289 | 2379918-42-8 | 2-Fluoro-5-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)benzaldehyde | C10H4F8O | 292.13 | | |
| 290 | 2379918-43-9 | 8-Chloro-6-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-3-amine hydrobromide | | | | |
| 291 | 2379918-44-0 | 2-Fluoro-5-cyclopropylphenol | C9H9FO | 152.17 | | |
| 292 | 2379918-45-1 | N-[1-(4-Fluorophenyl)ethyl]prop-2-yn-1-amine hydrochloride | | | | |
| 293 | 2379918-46-2 | N-[1-(3-Fluorophenyl)ethyl]prop-2-yn-1-amine hydrochloride | | | | |
| 294 | 2379918-47-3 | Ethyl 8-nitro-2-(trifluoromethyl)imidazo[1,2-a]pyridine-3-carboxylate | C11H8F3N3O4 | 303.19 | | |
| 295 | 2379918-49-5 | Ethyl 3-bromo-7-fluoroimidazo[1,2-a]pyridine-2-carboxylate | C10H8BrFN2O2 | 287.09 | | |
| 296 | 2379918-50-8 | 4,5-Dichloro-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-6-methylpyrimidine | C11H5Cl3F3N3 | 342.53 | | |
| 297 | 2379918-51-9 | N-[1-(3-Fluorophenyl)ethyl]cyclopropanamine hydrochloride | | | | |
| 298 | 2379918-52-0 | 1-(8-Chloro-3-(methylsulfonyl)-6-(trifluoromethyl)imidazo[1,5-a]pyridin-1-yl)-2,2,2-trifluoroethanone | C11H5ClF6N2O3S | 394.68 | | |
| 299 | 2379918-54-2 | Methyl 3-amino-7-(trifluoromethyl)-1-benzothiophene-2-carboxylate | C11H8F3NO2S | 275.25 | | |
| 300 | 2379918-55-3 | Benzo[b]thiophene-2-carboxylic acid, 3-amino-6-(trifluoromethyl)- | C10H6F3NO2S | 261.22 | | |
| 301 | 2379918-56-4 | 4-(6-Bromo-8-fluoroimidazo[1,2-a]pyridin-2-yl)benzonitrile | C14H7BrFN3 | 316.13 | | |
| 302 | 2379918-57-5 | Ethyl 6-bromo-8-fluoro-2-(trifluoromethyl)imidazo[1,2-a]pyridine-3-carboxylate | C11H7BrF4N2O2 | 355.08 | | |
| 303 | 2379918-60-0 | 5-(Trifluoromethyl)-2,3-dihydropyrrolo[2,3-b]pyridine, N1-BOC protected | C13H15F3N2O2 | 288.27 | | |
| 304 | 2379918-61-1 | Methyl 3-amino-4-(trifluoromethyl)-1-benzothiophene-2-carboxylate | C11H8F3NO2S | 275.25 | | |
| 305 | 2379928-06-8 | 6-Fluoro-2,3-dihydrospiro[1H-indene-1,4'-piperidine] trifluoroacetate | C15H17F4NO2 | 319.3 | | |
| 306 | 2379944-49-5 | 1-isopropyl-3-(trifluoromethyl)-1H-pyrazole-4-carbaldehyde | C8H9F3N2O | 206.17 | | |
| 307 | 2379974-45-3 | BDD26-2ThCl | | | | |
| 308 | 2379978-99-9 | (1-(3-cyclopropylmethoxy-4-methoxyphenyl)-2-(2,6-dimethyl-4-carbonylpyridin-1(4H)-yl)ethyl)hydroxide | | | | |
| 309 | 2379979-09-4 | 1-(2-(3-benzoxy-4-methoxyphenyl)-2-hydroxyethyl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 310 | 2379979-10-7 | 1-(2-(3-benzoxy-4-methoxyphenyl)-2-oxoethyl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 311 | 2379979-11-8 | 1-(2-(3-hydroxy-4-methoxyphenyl)-2-oxoethyl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 312 | 2379979-22-1 | 1-(2-(3-cyclopropylmethoxy-4-methoxyphenyl)-2-oxoethyl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 313 | 2379980-28-4 | 1-(2-(3-benzoxy-4-difluoromethoxyphenyl)-2-hydroxyethyl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 314 | 2379980-29-5 | 1-(2-(3-benzoxy-4-difluoromethoxyphenyl)-2-chloroethyl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 315 | 2379980-30-8 | (E)-1-(3-benzoxy-4-difluoromethoxystyryl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 316 | 2379980-31-9 | (E)-1-(3-hydroxy-4-difluoromethoxystyryl)-2,6-dimethylpyridin-4(1H)-one | | | | |
| 317 | 2379980-45-5 | Davalomilast | C20H21F2NO3S | 393.45 | | |
| 318 | 2379986-71-5 | 4-(PYRROLIDIN-1-YL)CYCLOHEXANE-1-CARBOXYLIC ACID HYDROCHLORIDE | | | | |
| 319 | 2379989-52-1 | N-[2-Cyclohexyl-4-(1-methylethyl)phenyl]-5-(tetrahydro-2H-pyran-2-yl)-2-furanmethanamine | C25H35NO2 | 381.55 | | |
| 320 | 2379995-76-1 | 3-Quinolinecarboxylic acid, 7-[4-(2-cyanoacetyl)-1-piperazinyl]-1-ethyl-6-fluoro-1,4-dihydro-4-oxo- | C19H19FN4O4 | 386.38 | | |